The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
L-type Amino Acid Transporter 1 (SLC7A5)-Mediated Transport of Pregabalin at the Rat Blood-Spinal Cord Barrier and its Sensitivity to Plasma Branched-Chain Amino Acids
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Taken together, these findings suggest that the BMD-001S are likely delivered to the spinal cord, at least in part via LAT1-mediated endocytosis or transcytosis, and are associated with reduced miR-485-3p expression in SOD1G93A transgenic mice.”
From Modulation of the miR-485-3p/PGC-1α Pathway by ASO-Loaded Nanoparticles Attenuates ALS Pathogenesis (2026) · cites this paper as [68]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 4F2hc/LAT1 complex transports l-DOPA across the blood–brain barrier
Kageyama, T., Nakamura, M., Matsuo, A., Yamasaki, Y., Takakura, Y., Hashida, M., Kanai, Y., Naito, M., Tsuruo, T., Minato, N., et al. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02758-x · Cited by 298
Effect of Infused Branched-Chain Amino Acids on Muscle and Whole-Body Amino Acid Metabolism in Man
Louard, R. J., Barrett, E. J., & Gelfand, R. A. (1990) · Clinical Science · doi:10.1042/cs0790457 · Cited by 157
Dosing Time-Dependent Changes in the Analgesic Effect of Pregabalin on Diabetic Neuropathy in Mice
Akamine, T., Koyanagi, S., Kusunose, N., Hashimoto, H., Taniguchi, M., Matsunaga, N., & Ohdo, S. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.223891 · Cited by 33
Research works printed but not linked: 31
- Colloca, 2017, Neuropathic pain, Nat Rev Dis Primers, 3, 1, 10.1038/nrdp.2017.2 · DOI
- Murphy, 2020, Peripheral neuropathic pain, NeuroRehabilitation, 47, 265
- Field, 2006, Identification of the α2-δ-1 subunit of voltage-calcium calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin, Proc Natl Acad Sci U S A, 103, 17537, 10.1073/pnas.0409066103 · DOI
- Chincholkar, 2018, Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review, Br J Anaesth, 120, 1315, 10.1016/j.bja.2018.02.066 · DOI
- Vongveeranonchai, 2014, Evaluation of a patient with spinal cord infarction after a hypotensive episode, Stroke, 45, e203, 10.1161/STROKEAHA.114.006490 · DOI
- Uchida, 2020, Comparison of absolute protein abundances of transporters and receptors among blood-brain barriers at different cerebral regions and the blood-spinal cord barrier in humans and rats, Mol Pharm, 17, 2006, 10.1021/acs.molpharmaceut.0c00178 · DOI
- Uchida, 2019, Involvement of claudin-11 in disruption of blood-brain, -spinal cord, and -arachnoid barriers in multiple sclerosis, Mol Neurobiol, 56, 2039, 10.1007/s12035-018-1207-5 · DOI
- Benet, 2011, BDDCS Applied to over 900 drugs, AAPS J, 13, 519, 10.1208/s12248-011-9290-9 · DOI
- Su, 2005, Mediation of highly concentrative uptake of pregabalin by L-type amino acid transport in Chinese hamster ovary and Caco-2 cells, J Pharmacol Exp Ther, 313, 1406, 10.1124/jpet.104.082255 · DOI
- Takahashi, 2018, Transport of pregabalin via L-type amino acid transporter 1 (SLC7A5) in human brain capillary endothelial cell line, Pharm Res, 35, 10.1007/s11095-018-2532-0 · DOI
- Toyooka, 2008, Up-regulation of L type amino acid transporter 1 after spinal cord injury in rats, Acta Neurochir Suppl (Wien), 385, 10.1007/978-3-211-85578-2_74 · DOI
- Lamhonwah, 2008, Expression patterns of the organic cation/carnitine transporter family in adult murine brain, Brain Dev, 30, 31, 10.1016/j.braindev.2007.05.005 · DOI
- Watson, 2013, Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier, BMC Neurosci, 14, 1, 10.1186/1471-2202-14-59 · DOI
- Noguchi, 2021, Substrate recognition of renally eliminated angiotensin II receptor blockers by organic anion transporter 4, Drug Metab Pharmacokinet, 36, 10.1016/j.dmpk.2020.10.002 · DOI
- Dhanikula, 2016, Evaluation of P-glycoprotein expression in pain relevant tissues: understanding translation of efflux from preclinical species to human, ADMET DMPK, 4, 261, 10.5599/admet.4.3.305 · DOI
- Oda, 2010, l-Type amino acid transporter 1 inhibitors inhibit tumor cell growth, Cancer Sci, 101, 173, 10.1111/j.1349-7006.2009.01386.x · DOI
- Yanagida, 2001, Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines, Biochim Biophys Acta Biomembr, 1514, 291, 10.1016/S0005-2736(01)00384-4 · DOI · Paper page
- del Amo, 2008, Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2, Eur J Pharm Sci, 35, 161, 10.1016/j.ejps.2008.06.015 · DOI
- Berry, 2005, Analysis of pregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLC, Ther Drug Monit, 27, 451, 10.1097/01.ftd.0000158874.54100.1a · DOI
- Takahashi, 2018, Transport of pregabalin via L-type amino acid transporter 1 (SLC7A5) in human brain capillary endothelial cell line, Pharm Res, 35, 246, 10.1007/s11095-018-2532-0 · DOI
- Blasberg, 1983, Transport of α-aminoisobutyric acid across brain capillary and cellular membranes, J Cereb Blood Flow Metab, 3, 8, 10.1038/jcbfm.1983.2 · DOI
- Otsuki, 2017, Prostate cancer cells in different androgen receptor status employ different leucine transporters, Prostate, 77, 222, 10.1002/pros.23263 · DOI
- Blum, 2021, Single-cell transcriptomic analysis of the adult mouse spinal cord reveals molecular diversity of autonomic and skeletal motor neurons, Nat Neurosci, 24, 572, 10.1038/s41593-020-00795-0 · DOI · Paper page
- Fukushima, 2007, Oral branched-chain amino acid supplementation improves the oxidized/reduced albumin ratio in patients with liver cirrhosis, Hepatol Res, 37, 765, 10.1111/j.1872-034X.2007.00123.x · DOI
- Zhang, 2011, Effects of branched-chain amino acid supplementation on plasma concentrations of free amino acids, insulin, and energy substrates in young men, J Nutr Sci Vitaminol (Tokyo), 57, 114, 10.3177/jnsv.57.114 · DOI
- Adibi, 1973, Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals, Journal of Clinical Investigation, 52, 1586, 10.1172/JCI107335 · DOI
- Kadota, 2012, Clofibrate-induced reduction of plasma branched-chain amino acid concentrations impairs glucose tolerance in rats, J Parenter Enter Nutr, 36, 337, 10.1177/0148607111414578 · DOI
- Knapik-Czajka, 2009, Adverse effect of fenofibrate on branched-chain α-ketoacid dehydrogenase complex in rat's liver, Toxicology, 266, 1, 10.1016/j.tox.2009.10.002 · DOI
- Cucca, 2015, Amino acid supplementation in l-dopa treated Parkinson's disease patients, Clin Nutr, 34, 1189, 10.1016/j.clnu.2014.12.007 · DOI
- Leenders, 1986, Inhibition ofL-{18F}fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography, Ann Neurol, 20, 258, 10.1002/ana.410200212 · DOI
- Dickens, 2013, Transport of gabapentin by LAT1 (SLC7A5), Biochem Pharmacol, 85, 1672, 10.1016/j.bcp.2013.03.022 · DOI
Cited by
Sorted by citations
Modulation of the miR-485-3p/PGC-1α Pathway by ASO-Loaded Nanoparticles Attenuates ALS Pathogenesis
Ryu, I. S., Ha, D.-I., Jung, Y.-J., Lee, H. J., Kim, I., Lim, Y. N., Min, H. S., Kim, S. H., Yoon, I., Cho, H.-J., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020615 · Cited by 2
Metadata
- Authors
- Akashi, T., Noguchi, S., Takahashi, Y., Nishimura, T., & Tomi, M.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2023-04
- Volume
- 112
- Issue
- 4
- Pages
- 1137-1144
- ISSN
- 0022-3549
- Cited by
- 8
- References
- 3
- Language
- en
- Licence
- Funders
- Japan Society for the Promotion of Science (18H03183, 21H02651, 22K20723)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review